Review Article
Myeloid-Derived microRNAs, miR-223, miR27a, and miR-652, Are Dominant Players in Myeloid Regulation
Table 1
Dominant miRNAs in human diseases.
| miRNA | Disease | Reference |
| miR-223, miR-16 | rheumatoid arthritis | [3] | miR-146 | rheumatoid arthritis | [9] | miR-223 | glioblastoma | [4] | miR-223 | breast cancer | [10] | miR-27 | breast cancer | [11] | miR-21 | colorectal cancer | [12] | miR-223 | acut myeloid leukemia | [13, 14] | miR-146b, -223, -29b, -29c, -483, -574-5p, -672 and -690 | chronic asthma | [15] | miR-21 | allergic airway inflammation | [16] | miR-223 | tuberculosis | [17] | miR-571 miR-652 | liver cirrhosis | [18] | miR-155 | many myeloproliferative disorders | [19] | miR-155 | multiple sclerosis | [20] | mi-R146A | systemic lupus erythematosus | [21] | miR-7 | Alzheimer disease | [22] | miR-132, miR-212 | Alzheimer disease | [23] | miR-132 | inflammatory bowel diseases | [24] |
|
|